Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories

$500m And Bigger

Databricks lays out $1.6bn in series H
UC Investments and the House Fund have invested in the data analytics software producer, which has been valued at $38bn in its series H round.
CMR Surgical seizes $600m
The surgical technology developer was valued at $3bn in a series C round backed by returning investor Cambridge Innovation Capital.
Celonis captures $1bn series D
TUM spinout Celonis has grown to Germany’s first decacorn, three years after becoming the university’s first unicorn.
FlixMobility picks up $650m
The UVC Partners-backed bus and train service hiked its valuation to $3bn in a series G debt and equity round that will fund the expansion of its routes.
SambaNova rams through $676m series D
The Stanford-linked artificial intelligence technology developer doubled its valuation to $5.1bn in a round led by SoftBank Vision Fund 2.
Databricks constructs $1bn series G
Advancing technology originating at UC Berkeley, Databricks has increased its valuation more than fourfold to $28bn and will use the funding to further scale its business.
Sila Nano slides in $590m
Georgia Tech-linked battery technology producer Sila Nanotechnologies has more than tripled its valuation to $3.3bn in the series F round.
CureVac completes $640m round
Tübingen's messenger RNA vaccine and drug developer's latest round includes a $171m investment by strategic partner GlaxoSmithKline.

Other News

Sana secures $700m
Sana Biotechnology has closed its first round with more than $700m after investors including GV swung behind its vision to commercialise cell therapies.
Oxford Nanopore to embrace $2.1bn round
Oxford Nanopore is reportedly eyeing a $2.1bn private placement that could offer an exit to Woodford Investment Management.
Lilium looks to Tencent for $500m round
Existing investor Tencent is in talks as part of a round TUM's flying car developer reportedly aims to close at between $400m and $500m.
FlixMobility books $561m series F
FlixMobility has raised a reported $561m in series F funding, adding to earlier capital provided by investors including TUM-linked UVC Partners and carmaker Daimler.
Parvus Therapeutics lands $800m in Genentech deal
University of Calgary-born Parvus Therapeutics has inked an $800m deal with Genentech to develop and commercialise treatments for autoimmune diseases.
Byton bids to raise $500m
Half a year after raising $500m in a TUS Holdings-backed series B round, the electric car developer is seeking another $500m before it floats.

Editor's Picks

No posts to show.

test reg